Cleared Traditional

K872579 - INNOFLUOR VANCOMYCIN REAGENT SET

K872579 is the FDA 510(k) clearance for INNOFLUOR VANCOMYCIN REAGENT SET by Innotron of Oregon, Inc.. It is a Class 2 Chemistry device (product code LEH) cleared through the Traditional 510(k) pathway after a 48-day FDA review.

K872579 · Innotron of Oregon, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1987
Decision
48d
Days
Class 2
Risk

K872579 is an FDA 510(k) clearance for the INNOFLUOR VANCOMYCIN REAGENT SET. Classified as Radioimmunoassay, Vancomycin (product code LEH), Class II - Special Controls.

Submitted by Innotron of Oregon, Inc. (Portland, US). The FDA issued a Cleared decision on August 17, 1987 after a review of 48 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.3950 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Innotron of Oregon, Inc. devices

Submission Details

510(k) Number K872579 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 30, 1987
Decision Date August 17, 1987
Days to Decision 48 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 88d · This submission: 48d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LEH Radioimmunoassay, Vancomycin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3950
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - LEH Radioimmunoassay, Vancomycin

All 23
Devices cleared under the same product code (LEH) and FDA review panel - the closest regulatory comparables to K872579.
ACA VANCOMYCIN (VANC) METHOD
K892900 · E.I. Dupont DE Nemours & Co., Inc. · May 1989
EMIT VANCOMYCIN ASSAY
K881040 · Syva Co. · Apr 1988
STRATUS VANCOMYCIN FLUOROMETRIC ENZYME IMMUNOASSAY
K874438 · Baxter Healthcare Corp · Jan 1988
VANCOMYCIN FLUORESCENT IMMUNOASSAY
K822308 · American Diagnostic Corp. · Aug 1982
TDX TM STREPTOMYCIN
K821136 · Abbott Laboratories · May 1982
TDX VANCOMYCIN
K813218 · Abbott Laboratories · Dec 1981